Organic Cation Transporter 1 Inhibitors
- Name
- Organic Cation Transporter 1 Inhibitors
- Accession Number
- DBCAT004054
- Description
Not Available
- Drugs
Drug Drug Description Crizotinib A receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive. Lorlatinib An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. - Drugs & Drug Targets